// November 27, 2023
Q&A: Building a More Resilient Medicines Supply Chain
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
The development of generic versions of innovator medicines is a global public health need.
There’s something about an anniversary that inspires me to look to the future as well as apprecia
By Katherine Bond, Sc.D., Vice President International Public Policy and Regulatory Affairs a